JohnCLaRosaMD

PubMed

• 397 citations
  Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
  Jane Armitage, Colin Baigent, Elizabeth H Barnes, D. John Betteridge, Lisa Blackwell, Michael A. Blazing, Louise Bowman, Eugene Braunwald, Robert P Byington, Christoph...> ;Lancet. 2019 Feb 2
• 11 citations
  Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease
  Lotte Kaasenbrood, Kausik K. Ray, S. Matthijs Boekholdt, Yvo M. Smulders, John C. LaRosa, John J.P. Kastelein, Yolanda van der Graaf, Jannick A N Dorresteijn, Frank L....> ;Heart. 2018 Apr 5
• 153 citations
  Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population
  Lotte Kaasenbrood, S. Matthijs Boekholdt, Yolanda van der Graaf, Kausik K. Ray, Ron J.G. Peters, John J.P. Kastelein, Pierre Amarenco, John C. LaRosa, Maarten J. Crame...> ;Circulation. 2016 Nov 8
• 13 citations
  Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study)
  James Shepherd, Andrei Breazna, Prakash Deedwania, John C. LaRosa, Nanette K. Wenger, Michael Messig, Daniel J. Wilson, Investigators> ;The American Journal of Cardiology. 2016 Apr 15
• 99 citations
  THE EFFECT OF STATIN THERAPY ON HEART FAILURE EVENTS: A COLLABORATIVE META-ANALYSIS OF UNPUBLISHED DATA FROM MAJOR RANDOMIZED TRIALS
  David Preiss, Ross T. Campbell, Heather Murray, Ian Ford, Chris J. Packard, Naveed Sattar, Kazem Rahimi, Helen M. Colhoun, David D. Waters, John C. LaRosa, Pierre Amar...> ;European Heart Journal. 2015 Jun 21
• 32 citations
  Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomar...
  Benoit J. Arsenault, Philip J. Barter, David A. DeMicco, Weihang Bao, Gregory M. Preston, John C. LaRosa, Scott M. Grundy, Prakash Deedwania, Heiner Greten, Nanette K....> ;Plos One. 2014 Dec 22
• 425 citations
  Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials
  S. Matthijs Boekholdt, G. Kees Hovingh, Samia Mora, Benoit J. Arsenault, Pierre Amarenco, Terje R. Pedersen, John C. LaRosa, David D. Waters, David A. DeMicco, R. John...> ;Journal of the American College of Cardiology. 2014 Aug 5
• 6 citations
  Treatment of cholesterol in the elderly: statins and beyond.
  John C. LaRosa> ;Current Atherosclerosis Reports. 2014 Jan 7
• 143 citations
  Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients A Meta-Analysis
  S. Matthijs Boekholdt, Benoit J. Arsenault, G. Kees Hovingh, Samia Mora, Terje R. Pedersen, John C. LaRosa, K M Welch, Pierre Amarenco, David A. DeMicco, Andrew Tonkin...> ;Circulation. 2013 Oct 1
• Living with imprecision.
  John C. LaRosa> ;Journal of the American College of Cardiology. 2013 Aug 20
• 31 citations
  High-Dose Statin Therapy in Patients With Stable Coronary Artery Disease Treating the Right Patients Based on Individualized Prediction of Treatment Effect
  Jannick A N Dorresteijn, S. Matthijs Boekholdt, Yolanda van der Graaf, John J.P. Kastelein, John C. LaRosa, Terje R. Pedersen, David A. DeMicco, Paul M. Ridker, Nancy ...> ;Circulation. 2013 Jun 25
• 1 citations
  Erratum: Prediction of cardiovascular events in statin-treated patients by lipid and non-lipid biomarkers (Journal of the American College of Cardiology (2011) 57 (63-...
  Benoit J. Arsenault, Philip J. Barter, David A. DeMicco, Weihang Bao, Gregory M. Preston, John C. LaRosa, Scott M. Grundy, Prakash Deedwania, Heiner Greten, Nanette K....> ;Journal of the American College of Cardiology. 2013 Apr 23
• 32 citations
  Safety and effect of very low levels of low-density lipoprotein cholesterol on cardiovascular events.
  John C. LaRosa, Terje R. Pedersen, Ransi Somaratne, Scott M. Wasserman> ;The American Journal of Cardiology. 2013 Apr 15
• 12 citations
  RETRACTED: Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease [Am Heart J 2012;164:387-393]
  Vera Bittner, Nanette K. Wenger, David D. Waters, David A. DeMicco, Michael Messig, John C. LaRosa> ;American Heart Journal. 2012 Sep 1
• 116 citations
  Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis
  David Preiss, Matti J. Tikkanen, Paul Welsh, Ian Ford, Laura C. Lovato, Marshall B. Elam, John C. LaRosa, David A. DeMicco, Helen M. Colhoun, Ilan Goldenberg, Michael ...> ;JAMA. 2012 Aug 22
• 5 citations
  Prediction of Cardiovascular Events in Patients with Ankylosing Spondylitis and Psoriatic Arthritis : Role of Lipoproteins in a High-risk Population
  Anne Grete Semb, Tore K Kvien, David A. DeMicco, Rana Fayyad, Chuan-Chuan Wun, John C. LaRosa, John Betteridge, Terje R. Pedersen, Ingar Holme> ;The Journal of Rheumatology. 2012 Jul 1
• 86 citations
  Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease†
  Anne Grete Semb, Tore K Kvien, David A. DeMicco, Rana Fayyad, Chuan-Chuan Wun, John C. LaRosa, John Betteridge, Terje R. Pedersen, Ingar Holme> ;Arthritis and Rheumatism. 2012 Sep 1
• 540 citations
  Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis
  S. Matthijs Boekholdt, Benoit J. Arsenault, Samia Mora, Terje R. Pedersen, John C. LaRosa, Paul J. Nestel, R. John Simes, Paul N. Durrington, Graham A. Hitman, K. M. A...> ;JAMA. 2012 Mar 28
• 17 citations
  The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end point...
  Benoit J. Arsenault, S. Matthijs Boekholdt, G. Kees Hovingh, Craig L. Hyde, David A. DeMicco, Aurobindo Chatterjee, Philip J. Barter, Prakash Deedwania, David D. Water...> ;Circulation. Cardiovascular Genetics. 2012 Feb 1
• 3 citations
  How Much Statin Intervention Is Enough
  John C. LaRosa> ;Journal of the American College of Cardiology. 2011 Oct 11
• The Editor's Roundtable: Closing the Clinical Practice Gap—Using Evidence-Based Treatments for Managing Lipids
  William C. Roberts, Antonio M. Gotto, John R. Guyton, John C. LaRosa, Ronald Viggiani> ;The American Journal of Cardiology. 2011 Jan 15
• 28 citations
  Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients by Lipid and Nonlipid Biomarkers
  Benoit J. Arsenault, Philip J. Barter, David A. DeMicco, Weihang Bao, Gregory M. Preston, John C. LaRosa, Scott M. Grundy, Prakash Deedwania, Heiner Greten, Nanette K....> ;Journal of the American College of Cardiology. 2011 Jan 4
• 5 citations
  On‐treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study
  Bas van den Bogaard, Bert-Jan H. van den Born, Rana Fayyad, David D. Waters, David A. DeMicco, John C. LaRosa, John J.P. Kastelein, Ingar Holme> ;European Journal of Clinical Investigation. 2011 Feb 1
• 275 citations
  J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.
  Sripal Bangalore, Franz H. Messerli, Chuan-Chuan Wun, Andrea Zuckerman, David A. DeMicco, John B. Kostis, John C. LaRosa> ;European Heart Journal. 2010 Dec 1
• 45 citations
  Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial)
  John C. LaRosa, Prakash Deedwania, James Shepherd, Nanette K. Wenger, Heiner Greten, David A. DeMicco, Andrei Breazna> ;The American Journal of Cardiology. 2010 Feb 1
• Join now to see all